Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4‐associated cholangitis from primary sclerosing cholangitis-Reference-Cited by-同舟云学术

Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4‐associated cholangitis from primary sclerosing cholangitis

Published:2014-04 Issue:5 Volume:59 Page:1954-1963
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Boonstra Kirsten¹,Culver Emma L.²,de Buy Wenniger Lucas Maillette¹,Heerde Marianne J.³,Erpecum Karel J.⁴,Poen Alexander C.⁵,Nieuwkerk Karin M.J.⁶,Spanier B.W. Marcel⁷,Witteman Ben J.M.⁸,Tuynman Hans A.R.E.⁹,Geloven Nan¹⁰,Buuren Henk³,Chapman Roger W.²,Barnes Eleanor²¹¹,Beuers Ulrich¹,Ponsioen Cyriel Y.¹

Affiliation:

1. Department of Gastroenterology and HepatologyAcademic Medical CenterAmsterdam the Netherlands

2. Translational Gastroenterology UnitJohn Radcliffe HospitalOxford United Kingdom

3. Department of Gastroenterology and HepatologyErasmus University Medical CenterRotterdam the Netherlands

4. Department of Gastroenterology and HepatologyUniversity Medical Center UtrechtUtrecht the Netherlands

5. Department of Gastroenterology and HepatologyIsala ClinicsZwolle the Netherlands

6. Department of Gastroenterology and HepatologyVU Medical CenterAmsterdam the Netherlands

7. Department of Gastroenterology and HepatologyRijnstate HospitalArnhem the Netherlands

8. Department of Gastroenterology and HepatologyGelderse Vallei HospitalEde the Netherlands

9. Department of Gastroenterology and HepatologyMedical Center AlkmaarAlkmaar the Netherlands

10. Clinical Research UnitAcademic Medical CenterAmsterdam the Netherlands

11. Oxford NIHR Biomedical Research Center, and NDM, University of OxfordOxford United Kingdom

Funder

Medical Research Council

Wellcome Trust

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.26977

Reference35 articles.

1. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review

2. Evolving concepts in primary sclerosing cholangitis

3. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis

4. High lifetime risk of cancer in primary sclerosing cholangitis

5. EASL Clinical Practice Guidelines: Management of cholestatic liver diseases

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic Tests in Primary Sclerosing Cholangitis;Clinics in Liver Disease;2024-02

2. Phenotypes of Primary Sclerosing Cholangitis and Differential Diagnosis;Clinics in Liver Disease;2024-02

3. Galectin-3 and prohibitin 1 are autoantigens in IgG4-related cholangitis without clear-cut protective effects against toxic bile acids;Frontiers in Immunology;2024-01-25

4. Complete Biochemical Remission With Oral Vancomycin in a Patient With Primary Sclerosing Cholangitis and High Serum Immunoglobulin G4 Levels;ACG Case Reports Journal;2024-01

5. Bile Duct Diseases;MacSween's Pathology of the Liver;2024